SAMH
NERV icon

Shanda Asset Management Holdings’s Minerva Neurosciences NERV Stock Holding History

Shanda Asset Management Holdings’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,075
Closed -$147K – 87
2020
Q2 		$147K Buy
+5,075
New +$298K 0.01% 90

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shanda Asset Management Holdings's NERV Position: Q3 2020 in Review

Shanda Asset Management Holdings sold out of Minerva Neurosciences (NERV) in Q3 2020, closing a stake of 5,075 shares — an estimated $147K sold.

Shanda Asset Management Holdings first reported a position in NERV in Q2 2020 and held it in 1 quarter. The position peaked at $147K in Q2 2020. 76 funds tracked by Wall St. Rank hold NERV as of Q3 2020.

  • Shanda Asset Management Holdings reported no remaining Minerva Neurosciences position as of Q3 2020 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 5,075 Minerva Neurosciences shares in Q3 2020, an estimated $147K.
  • Shanda Asset Management Holdings first reported a position in Minerva Neurosciences in Q2 2020 and held it in 1 quarter.
  • Shanda Asset Management Holdings's Minerva Neurosciences position peaked at $147K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2020.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.